An Alabama woman recently filed a federal lawsuit alleging that her use
of the anti-nausea drug Zofran during her pregnancy caused her son to
be born with birth defects.
A new lawsuit filed in the U.S. District Court in Birmingham accuses GlaxoSmithKline
of “negligent failure to warn, breach of warranty, negligence, wantonness,
and strict liability” over its anti-nausea drug
Zofran. The woman filing the suit claims that her use of the drug during her
pregnancy caused her son to be born with multiple birth defects, including
a high narrow pallet, extra fingers, a distended kidney, and glaucoma.
This is not the only lawsuit of its kind to be filed against GSK. There
is another one currently pending in the U.S. District Court of Montana
filed by a mother who claims taking Zofran during her first trimester
caused her son to be born with a cleft palate.
The parents in Alabama were both tested by a geneticist who ruled out chromosomal
issues as a possible causative factor, meaning the boy’s defects
are not genetic. The lawsuit claims that the boy will have to live with
these health issues for the rest of his life.
Studies of Zofran in the past had concluded that the drug did not cause
birth defects, but the most recent studies have found that women who take
Zofran during their pregnancy were at a 30 percent increased risk of having
children with birth defects such as cleft palate.
Domina Law Group is currently investigating claims involving GlaxoSmithKline’s
anti-nausea drug Zofran and its possible consequences for pregnant women.
If you took Zofran during your pregnancy and your son or daughter was
born with one or multiple defects, we invite you to contact our Omaha,
Nebraska injury lawyers for a review of your case.